Cross sectional PET study of cerebral adenosine A1 receptors in premanifest and manifest Huntington’s disease

Association between caffeine intake and age at onset in Huntington's disease

(2013) Clémence Simonin et al.   NEUROBIOLOGY OF DISEASE

18F-FDG PET uptake in the pre-Huntington disease caudate affects the time-to-onset independently of CAG expansion size

(2012) Andrea Ciarmiello et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data

(2011) Sarah J Tabrizi et al.   LANCET NEUROLOGY

Emotion recognition in Huntington's disease: A systematic review

(2011) Susie M.D. Henley et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

A New Drug Design Targeting the Adenosinergic System for Huntington's Disease

(2011) Nai-Kuei Huang et al.   PLoS One

Emotion recognition and experience in Huntington's disease: Is there a differential impairment?

(2011) Rottraut Ille et al.   PSYCHIATRY RESEARCH

Mitochondria in Huntington's disease

(2009) Maria Damiano et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Increased Cognitive Functioning in Symptomatic Huntington's Disease As Revealed by Behavioral and Event-Related Potential Indices of Auditory Sensory Memory and Attention

(2008) C. Beste et al.   JOURNAL OF NEUROSCIENCE

fMRI reveals altered auditory processing in manifest and premanifest Huntington's disease

(2008) Carsten Saft et al.   NEUROPSYCHOLOGIA